![[ Beasley Allen Law Firm Logo ]](http://www.fleetattorney.net/wp-content/themes/system-unity/images/logo.png){kind=logo}
Stool sampling may detect gastrointestinal cancers early
September 8th, 2009 by Jennifer Walker-Journey
Could samples of your stool keep you from having a colonoscopy? Researchers at Baylor Medical Center think so. A team of doctors from Baylor pored through stool samples, analyzed long strands of DNA and were able to diagnose gastrointestinal cancers early, according to a report from KARE-TV 11.
Beginning at age 50, or earlier for those with symptoms of colorectal cancer or a family history of the disease, we should have regular colonoscopies. However, half of the Americans who should have a colonoscopy don’t have the procedure because it is just too, well, gross. “It’s just the idea that someone is going to be examining the rectal area. They’re just uncomfortable with it,” says patient Adwinna Heads.
The team of researchers put their minds – and hands – to samples of fecal matter to see if a non-invasive technique could identify cancer early. Early on, colorectal cancers have no symptoms at all, which makes it such a deadly disease. What the researchers found is that they could diagnose early stage colorectal cancers in patients based on stool samples alone. This finding suggests that people who have the stool sample test performed may be able to avoid colonoscopies all together.
That is good news considering many people are squeamish about the procedure. Not only does it involve a day of preparation in close proximity to a toilet, it also requires another day for the procedure to be performed. The invasive process has few risks, but some bowel cleansing solutions used in the preparation have been linked to a serious kidney injury known as acute phosphate nephropathy. The type of product is known as oral sodium phosphate (OSP) and is in prescription brand tablets Visicol and Osmo Prep, as well as OTC products such as Fleet Phospho-soda and Fleet Accu-Prep.
